Apolipoprotein A-V level may contribute to the development of obesity-associated dyslipidemia.

Obes Res Clin Pract

Department of Pediatrics and Child Health, Nihon University School of Medicine 30-1, Oyaguchi Kamicho, Itabashi-ku, Tokyo 173-8610, Japan. Electronic

Published: July 2014

Aim: In a mice study, insulin suppressed apolipoprotein A-V (apoA-V) gene expression in a dose dependent manner. Thus, we investigated the association between apoA-V levels and dyslipidemias in obese children with hyperinsulinemia.

Methods: The subjects were 17 obese children (15 male, 2 female) aged 11.8 ± 2.4 years. Total cholesterol (TC), high-density lipoprotein cholesterol (HDLC), triglyceride (TG), apoA-V and insulin levels were determined.

Results: Obese children with hyperinsulinemia had greater percent overweight, higher TG level, lower HDLC level and lower apoA-V level than those without hyperinsulinemia. In simple regression analysis, apoA-V level correlated negatively with TG (r = -0.613, p = 0.0152) and insulin levels (r = -0.566, p = 0.0279), and positively correlated with HDLC (r = 0.811, p = 0.0002). In stepwise regression analysis, insulin level emerged as the independent determinant of TG level after apoA-V level was taken into account, whereas apoA-V emerged as the independent determinant of HDLC level after adjusting for insulin level.

Conclusions: Insulin may be a potent regulator of serum apoA-V level in obesity, and apoA-V level may partly contribute to the development of obesity-associated dyslipidemia.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.orcp.2012.08.192DOI Listing

Publication Analysis

Top Keywords

apoa-v level
20
obese children
12
level
11
apoa-v
9
apolipoprotein a-v
8
contribute development
8
development obesity-associated
8
obesity-associated dyslipidemia
8
insulin levels
8
level lower
8

Similar Publications

Comparison of the structure-function properties of wild-type human apoA-V and a C-terminal truncation associated with elevated plasma triglycerides.

medRxiv

February 2023

Division of Translational Medicine and Human Genetics, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

Background: Plasma triglycerides (TGs) are causally associated with coronary artery disease and acute pancreatitis. Apolipoprotein A-V (apoA-V, gene ) is a liver-secreted protein that is carried on triglyceride-rich lipoproteins and promotes the enzymatic activity of lipoprotein lipase (LPL), thereby reducing TG levels. Little is known about apoA-V structure-function; naturally occurring human variants can provide novel insights.

View Article and Find Full Text PDF

Primary hyperchylomicronemia is characterized by marked hypertriglyceridemia exceeding 1,000 mg/dL. It is caused by dysfunctional mutations in specific genes, namely those for lipoprotein lipase (LPL), glycosylphosphatidylinositol-anchored high-density lipoprotein binding protein 1 (GPIHBP1), apolipoprotein C2 (ApoC-II), lipase maturation factor 1 (LMF1), or apolipoprotein A5 (ApoA-V). Importantly, antibodies against LPL or GPIHBP1 have also been reported to induce autoimmune hyperchylomicronemia.

View Article and Find Full Text PDF

Context: Lipodystrophy syndromes cause hypertriglyceridemia that improves with leptin treatment using metreleptin. Mechanisms causing hypertriglyceridemia and improvements after metreleptin are incompletely understood.

Objective: Determine relationship of circulating lipoprotein lipase (LPL) modulators with hypertriglyceridemia in healthy controls and in patients with lipodystrophy before and after metreleptin.

View Article and Find Full Text PDF

The locus of the human proprotein convertase subtilisin-kexin type-7 (PC7) gene (PCSK7) is on chromosome 11q23.3 close to the gene cluster APOA5/APOA4/APOC3/APOA1, a region implicated in the regulation of lipoprotein metabolism. A GWAS reported the association of PCSK7 SNPs with plasma triglyceride (TG), and exome sequencing of African Americans revealed the association of a low-frequency coding variant of PC7 (R504H; SNP rs142953140) with a ~ 30% TG reduction.

View Article and Find Full Text PDF

High density lipoprotein promotes nascent apolipoprotein A-V secretion from mRNA transfected cells.

Biochem Biophys Res Commun

April 2019

Department of Biochemistry and Molecular Biology, University of Nevada, Reno, NV, 89557, USA. Electronic address:

Article Synopsis
  • ApoA-V plays a critical role in regulating plasma triacylglycerol levels despite being present in very low amounts in circulation.
  • Cells transfected with apoA-V mRNA showed that the protein was detected as early as 6 hours, with some secretion into the medium at 24 hours but most remaining inside the cells.
  • The secretion of apoA-V was influenced by the presence of external lipid particles, indicating that enhancing these particles could improve apoA-V's movement out of cells.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!